Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.020
+0.010 (0.99%)
At close: Mar 4, 2026, 4:00 PM EST
1.040
+0.020 (1.96%)
After-hours: Mar 4, 2026, 4:46 PM EST

Cardiol Therapeutics Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
11.6230.5834.9359.4783.914.03
Cash & Short-Term Investments
11.6230.5834.9359.4783.914.03
Cash Growth
-26.83%-12.46%-41.26%-29.12%498.20%101.62%
Accounts Receivable
0.040.10.140.210.070.01
Other Receivables
0.160.260.140.270.340.21
Total Trade Receivables
0.20.360.280.480.410.22
Inventory
-----0.36
Other Current Assets
0.990.730.941.492.830.35
Total Current Assets
12.8131.6736.1561.4487.1414.95
Net Property, Plant & Equipment
0.140.20.340.30.360.48
Other Intangible Assets
--0.210.290.380.46
Total Assets
12.9531.8636.762.0387.8815.89
Accounts Payable
3.256.988.049.334.862.47
Current Portion of Leases
0.040.030.020.050.040.05
Other Current Liabilities
--0.240.426.66-
Total Current Liabilities
3.297.018.39.811.572.52
Long-Term Leases
0.10.130.160.020.070.1
Total Long-Term Liabilities
0.10.130.160.020.070.1
Total Liabilities
3.397.148.459.8311.642.62
Common Stock
187.36179.34148.52147.55142.9251.92
Additional Paid-in Capital
28.124.6522.319.116.8413.23
Retained Earnings
-205.9-179.25-142.58-114.45-83.52-51.88
Shareholders' Equity
9.5624.7328.2552.276.2413.27
Total Liabilities & Equity
12.9531.8636.762.0387.8815.89
Total Debt
0.130.160.170.070.120.16
Net Cash (Debt)
11.4930.4234.7659.483.7813.87
Net Cash Growth
-62.24%-12.47%-41.48%-29.10%504.11%104.99%
Net Cash Per Share
0.140.420.540.951.940.46
Book Value
9.5624.7328.2552.276.2413.27
Book Value Per Share
0.120.350.440.841.760.44
Tangible Book Value
9.5624.7328.0451.9175.8612.81
Tangible Book Value Per Share
0.120.350.430.831.760.43
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q